Last reviewed · How we verify
Nebulized Lidocaine
Nebulized Lidocaine is a Small molecule drug developed by Hamad Medical Corporation. It is currently FDA-approved. Also known as: Nebulized Xylocaine, Lidocaine group.
At a glance
| Generic name | Nebulized Lidocaine |
|---|---|
| Also known as | Nebulized Xylocaine, Lidocaine group |
| Sponsor | Hamad Medical Corporation |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effects of Different Drugs for Glottic Atomization on Postoperative Sore Throat After Thyroid Surgery (PHASE4)
- Intraoperative Nebulization of Lidocaine and Postoperative Pulmonary Complications (PHASE3)
- Study on the Treatment of Post-stroke Dysphagia and Stroke-associated Pneumonia With Bronchoscopy (NA)
- Nebulized Lidocaine vs 3% Sodium Chloride in Pediatric Adenoid/Tonsil Surgery (NA)
- Effect of Nebulized Lignocaine on the Stress Response of Endotracheal Intubation in Pediatrics Undergoing Tonsillectomy Operation Monitored by Rise in Serum Cortisol Level Post Intubation (NA)
- Comparison of Nebulized Neostigmine/Atropine Versus Lignocaine in Treating Acute Post-dural Puncture Headache Following Subarachnoid Block in Parturient Undergoing Elective Cesarean Section. A Randomized, Clinical Trial. (EARLY_PHASE1)
- Nebulized Dexmedetomidine or Lidocaine for Treatment of Post Dural Puncture Headache in Parturients Undergoing Elective Cesarean Section Under Spinal Anesthesia (EARLY_PHASE1)
- Atomization Vs. Nebulization for Airway Topicalization During Awake Nasotracheal Fiberoptic Intubation (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nebulized Lidocaine CI brief — competitive landscape report
- Nebulized Lidocaine updates RSS · CI watch RSS
- Hamad Medical Corporation portfolio CI
Frequently asked questions about Nebulized Lidocaine
What is Nebulized Lidocaine?
Nebulized Lidocaine is a Small molecule drug developed by Hamad Medical Corporation.
Who makes Nebulized Lidocaine?
Nebulized Lidocaine is developed and marketed by Hamad Medical Corporation (see full Hamad Medical Corporation pipeline at /company/hamad-medical-corporation).
Is Nebulized Lidocaine also known as anything else?
Nebulized Lidocaine is also known as Nebulized Xylocaine, Lidocaine group.
What development phase is Nebulized Lidocaine in?
Nebulized Lidocaine is FDA-approved (marketed).
Related
- Manufacturer: Hamad Medical Corporation — full pipeline
- Also known as: Nebulized Xylocaine, Lidocaine group
- Compare: Nebulized Lidocaine vs similar drugs
- Pricing: Nebulized Lidocaine cost, discount & access